Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial

The only causative treatment for IgE-mediated allergies is allergen-specific immunotherapy. However, fewer than 5% of allergy patients receive immunotherapy because of its long duration and risk of allergic side effects. We aimed at enhancing s.c. immunotherapy by direct administration of allergen i...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Senti, Gabriela, Prinz Vavricka, Bettina M., Erdmann, Iris, Diaz, Mella I., Markus, Richard, McCormack, Stephen J., Simard, John J., Wüthrich, Brunello, Crameri, Reto, Graf, Nicole, Johansen, Pål, Kündig, Thomas M.
Format: Artigo
Jezik:Inglês
Izdano: National Academy of Sciences 2008
Teme:
Biological Sciences
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2582048/
https://ncbi.nlm.nih.gov/pubmed/19001265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0803725105
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki